ZA985704B - Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease - Google Patents

Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Info

Publication number
ZA985704B
ZA985704B ZA985704A ZA985704A ZA985704B ZA 985704 B ZA985704 B ZA 985704B ZA 985704 A ZA985704 A ZA 985704A ZA 985704 A ZA985704 A ZA 985704A ZA 985704 B ZA985704 B ZA 985704B
Authority
ZA
South Africa
Prior art keywords
diagnosis
prevention
compositions
surface antigens
lyme disease
Prior art date
Application number
ZA985704A
Other languages
English (en)
Inventor
Mario T Philipp
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of ZA985704B publication Critical patent/ZA985704B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA985704A 1997-06-30 1998-06-30 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease ZA985704B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5127197P 1997-06-30 1997-06-30

Publications (1)

Publication Number Publication Date
ZA985704B true ZA985704B (en) 1999-01-13

Family

ID=21970280

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985704A ZA985704B (en) 1997-06-30 1998-06-30 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Country Status (17)

Country Link
US (2) US6660274B2 (da)
EP (1) EP1012181B1 (da)
JP (1) JP2002511760A (da)
KR (1) KR20010020567A (da)
CN (1) CN1261896A (da)
AR (1) AR016295A1 (da)
AT (1) ATE337335T1 (da)
AU (1) AU8177298A (da)
CA (1) CA2294701C (da)
CO (1) CO4790101A1 (da)
DE (1) DE69835682T2 (da)
DK (1) DK1012181T3 (da)
ES (1) ES2270523T3 (da)
NO (1) NO996514L (da)
PL (1) PL337667A1 (da)
WO (1) WO1999000413A1 (da)
ZA (1) ZA985704B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733944T3 (de) * 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
WO1999000413A1 (en) * 1997-06-30 1999-01-07 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
AU2003299872A1 (en) 2002-12-20 2004-07-22 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia species and strains
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
MX2009004866A (es) 2006-11-03 2009-05-19 Schering Plough Ltd Vacuna para enfermedad de lyme canina.
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.
WO2009033163A2 (en) * 2007-09-07 2009-03-12 The Regents Of The University Of California Borrelia diagnostics and screening methods
WO2010132758A2 (en) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Ospc-based diagnostic test for lyme disease
EP2501719B1 (en) * 2009-11-17 2015-11-04 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US8623375B2 (en) * 2010-05-14 2014-01-07 Baxter International Inc. Chimeric OspA genes, proteins, and methods of use thereof
WO2012047607A2 (en) 2010-09-27 2012-04-12 Cornell University Methods for diagnosing lyme disease
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
AU2016311441B2 (en) 2015-08-27 2023-06-01 Ortho-Clinical Diagnostics, Inc. Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
EP4071477B1 (en) * 2015-09-25 2026-01-21 QIAGEN Sciences, LLC Compositions and methods for diagnosing lyme disease and for predicting lyme disease spirochete elimination after treatment
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CA3053110A1 (en) 2017-02-10 2018-08-16 Quidel Corporation Lateral flow assay with substrate having channels for controlled fluid flow
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法
WO2025049353A1 (en) 2023-08-25 2025-03-06 Focus on Lyme Foundation Multi-antigen diagnostic for detecting lyme disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485551A (en) 1892-11-01 And william
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
EP0339695A3 (en) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
ES2092560T5 (es) 1989-12-22 2004-09-16 Mikrogen Molekularbiologische Entwicklungs-Gmbh Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
WO1991013630A1 (en) 1990-03-05 1991-09-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce ANTIGENIC PROTEINS OF $i(BORRELIA BURGDORFERI)
SG122738A1 (en) 1990-06-15 2006-06-29 Univ Yale Compositions and methods for the prevention and diagnosis of lyme disease
IE912303A1 (en) 1990-07-06 1992-01-15 American Home Prod Vaccine against lyme disease and a challenge model for¹evaluating vaccine efficiency
DE69733944T3 (de) * 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
WO1999000413A1 (en) * 1997-06-30 1999-01-07 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease

Also Published As

Publication number Publication date
US20040067517A1 (en) 2004-04-08
CA2294701A1 (en) 1999-01-07
DE69835682T2 (de) 2007-08-23
ES2270523T3 (es) 2007-04-01
ATE337335T1 (de) 2006-09-15
CA2294701C (en) 2009-09-08
NO996514D0 (no) 1999-12-28
NO996514L (no) 2000-02-14
EP1012181A1 (en) 2000-06-28
EP1012181B1 (en) 2006-08-23
AR016295A1 (es) 2001-07-04
KR20010020567A (ko) 2001-03-15
US20030059894A1 (en) 2003-03-27
CN1261896A (zh) 2000-08-02
DK1012181T3 (da) 2007-01-02
PL337667A1 (en) 2000-08-28
AU8177298A (en) 1999-01-19
JP2002511760A (ja) 2002-04-16
CO4790101A1 (es) 1999-05-31
DE69835682D1 (de) 2006-10-05
WO1999000413A1 (en) 1999-01-07
US6660274B2 (en) 2003-12-09

Similar Documents

Publication Publication Date Title
AU8177298A (en) Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
EP0727225A3 (en) Compositions and methods for directed ultrasonic imaging
IL195649A0 (en) Compositions comprising anti-??v??3 recombinant human antibodies and nucleic acids encoding the same
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
EP0536335A4 (en) Compositions and methods for the prevention and diagnosis of lyme disease
ZA9810130B (en) Tumor-specific antigens methods for their production and their use for imunization and diagnosis
AU2991697A (en) Methods of diagnosing clinical subtypes of crohn's disease
GB9709404D0 (en) Improvements in or relating to the formation of images
EP0934427A4 (en) RH BLOOD GROUP ANTIGEN COMPOSITIONS AND METHODS OF USE
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
PT1025100E (pt) Derivados de tetra-hidropiridopirimidona substituidos na posicao 3 sua preparacao e sua utilizacao
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
IL118407A (en) Polymyxin dextran conjugates their preparation and pharmaceutical compositions containing them
EP0987942A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE
AU7836798A (en) Compositions for delivery of biological agents and methods for the preparation thereof
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU3665699A (en) Compositions and methods for tolerization in immune complex-mediated disease progression
GB9515754D0 (en) Compositions and methods for the prevention of symptoms of viral disease
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders